-
J&J MedTech Launches Locally Produced HARMONIC 7s Scalpel in China
•
Johnson & Johnson MedTech, a US-based healthcare giant, announced the official launch of its HARMONIC 7s ultrasonic scalpel instrument in China, marking a milestone with local production at its Suzhou plant. Product HighlightsThe HARMONIC 7s features an innovative built-in intelligent chip and proprietary next-generation adaptive tissue algorithm (ATT), enabling continuous…
-
Johnson & Johnson MedTech’s Dual Energy Catheter Gains CE Mark
•
US major Johnson & Johnson MedTech has announced that its Dual Energy THERMOCOOL SMARTTOUCH SF Catheter has obtained the European CE mark for the treatment of cardiac arrhythmias. This approval is a significant milestone in the expansion of the company’s electrophysiology portfolio, offering a new treatment option for patients suffering…
-
Johnson & Johnson MedTech’s Impella Heart Pumps Gain FDA Approval for Pediatric Heart Failure
•
US major Johnson & Johnson MedTechhas announced receiving premarket approval (PMA) from the US Food and Drug Administration (FDA) for its Impella 5.5 with SmartAssist and Impella CP with SmartAssist heart pumps. This approval expands their indications to include specific pediatric patients with symptomatic acute decompensated heart failure (ADHF) and…
-
Johnson & Johnson MedTech’s QDOT Catheter Approved in China for Atrial Fibrillation
•
Johnson & Johnson MedTech’s next-generation QDOT micro diagnostic/ablation deflectable tip catheter, a disposable pressure monitoring radiofrequency catheter, has been approved for marketing in China. This innovative device is set to serve as a novel solution for the treatment of atrial fibrillation, marking a significant advancement in the field of electrophysiology.…
